+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter



Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter



Journal of Clinical Pharmacy and Therapeutics 41(6): 684-688



Patients with schizophrenia are most commonly treated with antipsychotic medications, often with the addition of anxiolytics. This study used an oral moisture meter to evaluate xerostomia in patients with schizophrenia taking typical and atypical antipsychotics, anxiolytics and non-psychotropic medications. Patients diagnosed with schizophrenia according to ICD-10 criteria in the Department of Psychiatry, Kitasato University East, and affiliated hospitals were studied. All patients were on psychotropic medications. Patients with diseases associated with xerostomia, such as Sjögren's syndrome I, were excluded. A total of 127 patients were enrolled. Mean oral moisture was 27·81 ± 2·27% (normal, ≥30·0%). A significant association was observed between objective oral moisture and the subjective sense of dry mouth. Multivariate analysis revealed a negative correlation between the number of antipsychotics and, especially, anxiolytics, and the degree of oral moisture. Drug dosages themselves were not significantly correlated with dry mouth. These findings suggest that objective oral moisture measurements show decreased moisture in patients on these medications and that the degree of moisture shows a greater negative correlation with the number, as opposed to the dosages, of psychotropic drugs administered. When patients with schizophrenia visit a dental clinic, it is important for the dentist to accurately assess the degree of oral moisture and to determine the medications being taken. Based on these findings of the association of polypharmacy with xerostomia, dentists are encouraged to inform the psychiatrist of the need to actively manage patients' xerostomia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058731447

Download citation: RISBibTeXText

PMID: 27663579

DOI: 10.1111/jcpt.12449


Related references

Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies. Australian and New Zealand Journal of Psychiatry 45(3): 193-198, 2011

Integrated management of patients with schizophrenia: beyond psychotropic drugs. Revista Colombiana de Psiquiatria 45(2): 118-123, 2016

Drug induced xerostomia and severe dental pathology: the role of psychotropic drugs. Journal of Hospital Dental Practice 5(3): 122-125, 1971

Mental representation of drugs: construction of two questionnaires to study patients treated with psychotropic or oral hypoglycemic drugs. AnnalesMedico-Psychologiques153(8):536, 1995

The fixing action of psychotropic drugs in the treatment of patients with schizophrenia. Tr Mosk Nauch Issled Inst Psikhiat 48: 57-58, 1966

The action of different psychotropic drugs on speech disturbances in patients with schizophrenia. Anon Vtoroi Vserossiiskii S"ezd Nevropathologov I Psikhiatrov, (The Second All-Russian Session Of Neuropathologists And Psychiatrists, From Ref Zh 1968, No 7 54 634-636, 1967

Effects of Psychotropic Drugs on Quantitative EEG among Patients with Schizophrenia-spectrum Disorders. Clinical Psychopharmacology and Neuroscience 9(2): 78-85, 2011

The use of a combination of methionine and some psychotropic drugs in the treatment of patients with chronic schizophrenia. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 69(12): 1868-1871, 1969

Use of a combination of methionine and various psychotropic drugs in the treatment of chronic schizophrenia patients. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 69(12): 1868-1871, 1969

Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey. European Journal of Clinical Pharmacology 60(7): 513-522, 2004

Efficacy of various psychotropic drugs and their combinations in patients with early started malignant schizophrenia. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 81(1): 114-121, 1981

The dynamics of disturbances of the emotions and the will and their regression in patients with schizophrenia under the action of treatment with psychotropic drugs. Anon Vtoroi Vserossiiskii S"ezd Nevropathologov I Psikhiatrov, (The Second All-Russian Session Of Neuropathologists And Psychiatrists, From Ref Zh 1968, No 7 54 538-540, 1967

Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. Journal of Clinical Psychopharmacology 27(5): 437-443, 2007

Treatment of therapy resistant patients with paranoid schizophrenia with moditen depot combined with other psychotropic drugs and leponex. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 80(8): 1211-1216, 1280, 1980

Studies on the electric moisture meter for tobacco. II. On the performance of a microwave attenuation moisture meter. 1977